Cargando…

Targeted Therapies in Cancer: To Be or Not to Be, Selective

Development of targeted therapies in recent years revealed several nonchemotherapeutic options for patients. Chief among targeted therapies is small molecule kinase inhibitors targeting key oncogenic signaling proteins. Through competitive and noncompetitive inhibition of these kinases, and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montoya, Skye, Soong, Deborah, Nguyen, Nina, Affer, Maurizio, Munamarty, Sailasya P., Taylor, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615814/ https://www.ncbi.nlm.nih.gov/pubmed/34829820 http://dx.doi.org/10.3390/biomedicines9111591

Ejemplares similares

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022)

Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
por: Stanchina, Michele, et al.
Publicado: (2020)

Non-Covalent Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia
por: Montoya, Skye, et al.
Publicado: (2023)

Target selection for CAR-T therapy
por: Wei, Jianshu, et al.
Publicado: (2019)

Bispecific antibodies in cancer therapy: Target selection and regulatory requirements
por: Sun, Yanze, et al.
Publicado: (2023)

Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer
por: Leamon, Christopher P, et al.
Publicado: (2013)

Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
por: Wu, Qinghua, et al.
Publicado: (2020)

Eclipse Rich Client Platform: designing, coding, and packaging Java applications
por: McAffer, Jeff, et al.
Publicado: (2005)

SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020)

Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy
por: Lee, Min Ju, et al.
Publicado: (2023)

AhR and Cancer: From Gene Profiling to Targeted Therapy
por: Paris, Anaïs, et al.
Publicado: (2021)

Oncolytic viral therapy: targeting cancer stem cells
por: Smith, Tyrel T, et al.
Publicado: (2014)

Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

The genomic map of breast cancer: which roads lead to better targeted therapies?
por: Balko, Justin M, et al.
Publicado: (2013)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
por: Kerr, Caroline P., et al.
Publicado: (2022)

Recent advancements in PARP inhibitors-based targeted cancer therapy
por: Zhou, Ping, et al.
Publicado: (2020)

RNA-based Gene Therapy for the Treatment and Prevention of HIV: From Bench to Bedside
por: Zeller, Skye J., et al.
Publicado: (2011)

Further phenotypic characterization of the primitive lineage− CD34+CD38−CD90+CD45RA− hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia
por: Wisniewski, D, et al.
Publicado: (2011)

Eclipse Rich Client Platform: designing, coding, and packaging Java applications
por: McAffer, Jeff, et al.
Publicado: (2010)

Equinox and OSGi: the power behind Eclipse
por: McAffer, Jeff, et al.
Publicado: (2009)

Molecularly Targeted Therapies for Gastric Cancer. State of the Art
por: Reddavid, Rossella, et al.
Publicado: (2021)

Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy
por: Choromańska, Anna, et al.
Publicado: (2021)

Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies
por: Nguyen, Thuy-Tien T, et al.
Publicado: (2023)

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment
por: Soong, Deborah, et al.
Publicado: (2021)

Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option
por: Messex, Justin K., et al.
Publicado: (2021)

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
por: Nguyen, Ngoc Minh, et al.
Publicado: (2022)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

TACkling Cancer by Targeting Selective Protein Degradation
por: Noblejas-López, María del Mar, et al.
Publicado: (2023)

Targeted Therapy in Ovarian Cancer
por: Willmott, Lyndsay J., et al.
Publicado: (2010)

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
por: Wang, Xinning, et al.
Publicado: (2021)

Targeting Mnks for Cancer Therapy
por: Hou, Jinqiang, et al.
Publicado: (2012)

Targeted Therapies for Pancreatic Cancer
por: Amanam, Idoroenyi, et al.
Publicado: (2018)

Targeted therapy in cervical cancer
por: Vora, Chakor, et al.
Publicado: (2019)

Targeting epigenetics for cancer therapy
por: Park, Jong Woo, et al.
Publicado: (2019)

Selective antagonism of cJun for cancer therapy
por: Brennan, Andrew, et al.
Publicado: (2020)

Bioinformatics roadmap for therapy selection in cancer genomics
por: Jiménez‐Santos, María José, et al.
Publicado: (2022)

Testosterone therapy and prostate cancer
por: Pastuszak, Alexander W., et al.
Publicado: (2016)

Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
por: Wolska, Nina, et al.
Publicado: (2019)

Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids
por: Viola, Joana R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2fb7su2dua3srv4rmsm9eu4l5g